The Effectiveness of a Relaxation Technique on the Quality of Life and Symptoms in People Living With HIV

The Effectiveness of a Relaxation Technique on the Quality of Life and Symptoms in People Living With HIV

Sponsors

Lead Sponsor

Collaborators

Source

Université de Montréal

Oversight Info

Has Dmc

No

Is Fda Regulated Drug

No

Is Fda Regulated Device

No

Brief Summary

Quality of life of people living with HIV is strongly affected by the presence of one or more
symptoms, such as sleep problems, fatigue, muscle pain, anxiety and depressive symptoms.
Autogenic training has shown positive effects on these symptoms in different populations, but
there is very little evidence on the effects of this relaxation technique in people living
with HIV.

Detailed Description

The aim of this project is to evaluate the effectiveness of a relaxation technique, autogenic
training, on the quality of life and the physical and psychological symptoms in people living
with HIV.

Enrollment

Condition

Intervention

Intervention Type

Intervention Name

Description

autogenic training

Arm Group Label

autogenic training

wait list

Eligibility

Criteria

Inclusion Criteria:
- Being older than 18 ;
- have a diagnosis of HIV;
- present at least one of the following symptoms during the preceding two weeks: sleep
problems, fatigue, pain, anxiety or symptoms of depression;
- understand and speak French and;
- be able to follow the instructions to learn the relaxation technique.
Exclusion Criteria:
-

Intervention Model

Primary Purpose

Masking

Study First Submitted

Study First Submitted Qc

Study First Posted

April 23, 2019

Last Update Submitted

September 9, 2019

Last Update Submitted Qc

September 9, 2019

Last Update Posted

September 11, 2019

ClinicalTrials.gov processed this data on September 13, 2019

Conditions

Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.

Interventions

Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.

Study Phase

Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:

In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment
in a small group of people (20-80) for the first time to evaluate its
safety, determine a safe dosage range, and identify side effects.

In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to
a larger group of people (100-300) to see if it is effective and to
further evaluate its safety.

In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to
large groups of people (1,000-3,000) to confirm its effectiveness,
monitor side effects, compare it to commonly used treatments, and
collect information that will allow the drug or treatment to be used
safely.